Pasithea Therapeutics Corp. financial data

Symbol
KTTA, KTTAW on Nasdaq
Location
1111 Lincoln Road, Suite 500, Miami Beach, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 475 % -29.7%
Debt-to-equity 11.3 % +15.3%
Return On Equity -97.9 % -19.9%
Return On Assets -88 % -18.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.44M shares +488%
Common Stock, Shares, Outstanding 7.44M shares +612%
Entity Public Float 4.1M USD -61%
Common Stock, Value, Issued 743 USD +614%
Weighted Average Number of Shares Outstanding, Basic 7.44M shares +613%
Weighted Average Number of Shares Outstanding, Diluted 7.44M shares +613%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.75M USD -25.4%
General and Administrative Expense 1.75M USD +23.1%
Operating Income (Loss) -13.9M USD +14.1%
Nonoperating Income (Expense) 366K USD -3.88%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.5M USD +14.4%
Net Income (Loss) Attributable to Parent -13.5M USD +14.5%
Earnings Per Share, Basic -0.41 USD/shares +85.7%
Earnings Per Share, Diluted -0.41 USD/shares +85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.12M USD -56%
Other Assets, Current 19.7K USD -80%
Assets, Current 5.53M USD -43.5%
Property, Plant and Equipment, Net 114K USD -13.8%
Operating Lease, Right-of-Use Asset 32K USD -93%
Intangible Assets, Net (Excluding Goodwill) 6.84M USD -8.44%
Goodwill 1.26M USD 0%
Assets 13.6M USD -26.9%
Liabilities, Current 1.38M USD +109%
Operating Lease, Liability, Noncurrent 211K USD -70.9%
Liabilities 1.42M USD +72.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 18.3K USD
Retained Earnings (Accumulated Deficit) -59.9M USD -29.1%
Stockholders' Equity Attributable to Parent 12.2M USD -31.5%
Liabilities and Equity 13.6M USD -26.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.06M USD +29.3%
Net Cash Provided by (Used in) Financing Activities 1.47M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.44M shares +612%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.58M USD +63.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.22M USD -54.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.89K USD
Deferred Tax Assets, Valuation Allowance 0 USD
Deferred Tax Assets, Gross 11.8M USD +54.6%
Operating Lease, Liability 33K USD -92.9%
Depreciation 4K USD -20%
Payments to Acquire Property, Plant, and Equipment 53.9K USD +2662%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.4M USD +14.9%
Lessee, Operating Lease, Liability, to be Paid 33.3K USD
Property, Plant and Equipment, Gross 162K USD -1.94%
Operating Lease, Liability, Current 33K USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 83.3K USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 323 USD -99.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 183K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 72.1M USD +12.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +53.6%
Share-based Payment Arrangement, Expense 97K USD -67.5%
Operating Leases, Future Minimum Payments Due 83.3K USD
Interest Expense -117K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%